fbpx

Essilor International climbs on Forbes’ list

Essilor International is up five spots and now ranks 23rd on Forbes Magazine’s list of the 100 most innovative companies in 2013.

 

For Forbes, the most innovative companies are those that are most likely to succeed in the future. Essilor International ranks as the 5th most innovative company in Europe, and the 2nd most innovative in France.  The magazine based this ranking on the more than $200 million that Essilor invests in R&D each year, its three Innovation and Technology Centres and its 500 researchers on various continents. Approximately 40% of Essilor’s annual sales are generated from products launched over the last three years.

 

Quebec-based Valeant Pharmaceuticals, which recently acquired Bausch+Lomb, ranks 62nd. The company, whose sales have increased by over 36% in the 12 months preceding the release of the list, is the only Canadian company to be included on the list.

 

Other industry players are also named, such as Regeneron (4th), whose drug Eylea is a major competitor for Lucentis in the treatment of AMD, and might also be used to treat diabetic macular edema. LVMH Moet Hennessy Louis Vuitton came in 75th place, whereas adidas is in 92nd place.

Sources:

 

http://www.forbes.com/innovative-companies/list/

http://www.acuite.fr/articles.asp?REF=8910

Featured Posts

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Learn More
OptikConED Year end special

Year-End Continuing Education Special: For Opticians and Optometric Assistants

From now until December 31, OptikConED.com offers year-end CE specials starting at $8.95 per course.

Read more

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Read more

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read more

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read more

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Learn More
OptikConED Year end special

Year-End Continuing Education Special: For Opticians and Optometric Assistants

From now until December 31, OptikConED.com offers year-end CE specials starting at $8.95 per course.

Read More

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Read More

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read More

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read More

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Learn More
OptikConED Year end special

Year-End Continuing Education Special: For Opticians and Optometric Assistants

From now until December 31, OptikConED.com offers year-end CE specials starting at $8.95 per course.

Read more

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Read more

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read more

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read more

Trinity Capital Provides $45 Million Growth Capital To Neurolens

Trinity Capital Inc., a leading provider of diversified financial solutions to growth-stage companies, announced the commitment of $45 million in growth capital to Neurolens.

Learn More
OptikConED Year end special

Year-End Continuing Education Special: For Opticians and Optometric Assistants

From now until December 31, OptikConED.com offers year-end CE specials starting at $8.95 per course.

Read more

EssilorLuxottica and Moncler Announce Exclusive Licensing Agreement

EssilorLuxottica and Moncler have announced the signing of an exclusive licensing agreement that includes the design, production, and global distribution of Moncler eyewear.

Read more

OSI National Summit 2023: A Milestone Gathering Redefining the Future of Independent Optometry

Taking place at Toronto’s Westin Harbour Castle from November 17 to 19, the 2023 OSI National Summit brought together optometrists, opticians, optometric assistants, managers, and staff.

Read more

Diversity and Inclusion in Eye Care

Canada is an intricate textured tapestry of different cultures. Each patient is unique and presents with different preferences and lifestyle choices.

Read more